Per Artikel

Riset dan Pengabdian Masyarakat Do Research Sosial Service and Innovation

Id	Authors	Author S Id	Title	Year	Source Title	Volume	Issue	Art No	Page Start	Page End	Cited By	Link	Affiliations	Authors With Affiliations	Abstract	Index Keywords	Publisher	Issn	Pubmed Id	Document Type	Sjr Best Quartile	Sjr	Sjr Rank
Display # Page 4 of 93 Start Prev 1 2 3 4 5 6 7 8 9 10 Next End
(10)
No records
216	Pawankar R., Thong B.Y.-H., Tiongco-Recto M., Wang J.-Y., Abdul Latiff A.H., Thien F., Oh J.-W., Kamchaisatian W., Rengganis I., Udwadia Z.F., Dhar R., Munkhbayarlakh S., Narantsetseg L., Le Pham D., Leung T.F., Zhang L., APAAACI COVID-19 Working Group	7005904460;6603816215;55359899500;56499349900;55608026700;57204250177;55657464600;6505855073;8449988000;57192641184;7006700626;56800881300;8977752900;57201431490;57225672394;36068675900;	Asia-Pacific perspectives on the COVID-19 pandemic	2021	Allergy: European Journal of Allergy and Clinical Immunology	76	9		2998	2901	2	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85106213191&doi=10.1111%2fall.14894&partnerID=40&md5=a8dda5140c82a54f09e8a12b2804a47c	Division of Allergy, Department of Pediatrics, Nippon Medical School, Tokyo, Japan; Department of Rheumatology, Allergy and Immunology, Tan Tock Seng Hospital, Singapore City, Singapore; Division of Allergy and Immunology, Department of Pediatrics, University of the Philippines-Philippine General Hospital, Manila, Philippines; Centre of Allergy and Clinical Immunology Research (ACIR), Department of Paediatrics, National Cheng Kung University Hospital, Tainan, Taiwan; Allergy & Immunology Centre Pantai Hospital, Kuala Lumpur, Malaysia; Department of Paediatrics, Universiti Putra Malaysia Teaching Hospital, Kuala Lumpur, Malaysia; Eastern Health, Monash University, Melbourne, Vic, Australia; Department of Pediatrics, Hanyang University Guri Hospital, Guri, Gyunggi-Do, South Korea; Pediatric Allergy and Immunology Division, Samitivej Children’s Hospital, Bangkok, Thailand; Division of Allergy and Clinical Immunology, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia, CiptoMangunkusumo General Hopsital, Jakarta, Indonesia; P.D. Hinduja National Hospital and Medical Research Centre and the Breach Candy Hospital, Mumbai, India; Department of Pulmonology, C K BIRLA Group of Hospitals, CMRIKolkata, India; Department of Pulmonology and Allergology, School of Medicine, Mongolian National University of Medical Sciences, Ulaanbaatar, Mongolia; Department of Biochemistry, School of Biomedicine, MongolianNational University of Medical Sciences, Ulaanbaatar, Mongolia; Faculty of Medicine, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Viet Nam; Department of Pediatrics, Chinese University of Hong Kong, Hong Kong; Department of Otolaryngology Head and Neck Surgery, Beijing TongRen Hospital, Capital Medical University, Beijing, China	Pawankar, R., Division of Allergy, Department of Pediatrics, Nippon Medical School, Tokyo, Japan; Thong, B.Y.-H., Department of Rheumatology, Allergy and Immunology, Tan Tock Seng Hospital, Singapore City, Singapore; Tiongco-Recto, M., Division of Allergy and Immunology, Department of Pediatrics, University of the Philippines-Philippine General Hospital, Manila, Philippines; Wang, J.-Y., Centre of Allergy and Clinical Immunology Research (ACIR), Department of Paediatrics, National Cheng Kung University Hospital, Tainan, Taiwan; Abdul Latiff, A.H., Allergy & Immunology Centre Pantai Hospital, Kuala Lumpur, Malaysia, Department of Paediatrics, Universiti Putra Malaysia Teaching Hospital, Kuala Lumpur, Malaysia; Thien, F., Eastern Health, Monash University, Melbourne, Vic, Australia; Oh, J.-W., Department of Pediatrics, Hanyang University Guri Hospital, Guri, Gyunggi-Do, South Korea; Kamchaisatian, W., Pediatric Allergy and Immunology Division, Samitivej Children’s Hospital, Bangkok, Thailand; Rengganis, I., Division of Allergy and Clinical Immunology, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia, CiptoMangunkusumo General Hopsital, Jakarta, Indonesia; Udwadia, Z.F., P.D. Hinduja National Hospital and Medical Research Centre and the Breach Candy Hospital, Mumbai, India; Dhar, R., Department of Pulmonology, C K BIRLA Group of Hospitals, CMRIKolkata, India; Munkhbayarlakh, S., Department of Pulmonology and Allergology, School of Medicine, Mongolian National University of Medical Sciences, Ulaanbaatar, Mongolia; Narantsetseg, L., Department of Biochemistry, School of Biomedicine, MongolianNational University of Medical Sciences, Ulaanbaatar, Mongolia; Le Pham, D., Faculty of Medicine, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Viet Nam; Leung, T.F., Department of Pediatrics, Chinese University of Hong Kong, Hong Kong; Zhang, L., Department of Otolaryngology Head and Neck Surgery, Beijing TongRen Hospital, Capital Medical University, Beijing, China; APAAACI COVID-19 Working Group	[No abstract available]	biological product; chloroquine; convalescent plasma; corticosteroid; hydroxychloroquine; immunosuppressive agent; lopinavir plus ritonavir; remdesivir; tocilizumab; asthma; chronic rhinosinusitis; coronavirus disease 2019; desensitization; device infection; eye allergy; health care access; health care policy; health care survey; human; immunosuppressive treatment; infection control; infection prevention; latex allergy; Letter; medical device complication; mutation; pandemic; phenotype; protective glasses; questionnaire; Asia; epidemiology; pandemic; Asia; COVID-19; Humans; Pandemics; SARS-CoV-2	John Wiley and Sons Inc	01054538	33948966	Letter	Q1	3363	542	View
219	Amarra M.S., Chong M.F.-F., Titapant V., Somprasit C., Rogacion J., Irwinda R., Huynh T.N.K., Nalliah S.	26024123300;16302916300;6602085502;8440614700;6508291071;57205713130;57221814418;25422423000;	ILSI Southeast Asia symposium: prevalence, risk factors, and actions to address gestational diabetes in selected Southeast Asian countries	2021	European Journal of Clinical Nutrition	75	9		1303	1308		https://www.scopus.com/inward/record.uri?eid=2-s2.0-85100287487&doi=10.1038%2fs41430-020-00838-6&partnerID=40&md5=968eff6db95c2d745843171831db19e3	Department of Food Science and Nutrition, College of Home Economics, University of the Philippines Diliman, Quezon, Philippines; Saw Swee Hock School of Public Health, National University of Singapore, Singapore, Singapore; Department of Obstetrics and Gynecology, Faculty of Medicine, Siriraj Hospital Mahidol University, Bangkok, Thailand; Department of Obstetrics and Gynecology, Faculty of Medicine, Thammasat University, Bangkok, Thailand; Department of Pediatrics, University of the Philippines, Manila, Philippines; Department of Obstetrics and Gynecology, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Department of Obstetrics and Gynecology, Pham Ngoc Thach University of Medicine, Ho Chi Minh, Viet Nam; Division of Obstetrics & Gynaecology, Clinical School, International Medical University, Seremban, Malaysia	Amarra, M.S., Department of Food Science and Nutrition, College of Home Economics, University of the Philippines Diliman, Quezon, Philippines; Chong, M.F.-F., Saw Swee Hock School of Public Health, National University of Singapore, Singapore, Singapore; Titapant, V., Department of Obstetrics and Gynecology, Faculty of Medicine, Siriraj Hospital Mahidol University, Bangkok, Thailand; Somprasit, C., Department of Obstetrics and Gynecology, Faculty of Medicine, Thammasat University, Bangkok, Thailand; Rogacion, J., Department of Pediatrics, University of the Philippines, Manila, Philippines; Irwinda, R., Department of Obstetrics and Gynecology, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Huynh, T.N.K., Department of Obstetrics and Gynecology, Pham Ngoc Thach University of Medicine, Ho Chi Minh, Viet Nam; Nalliah, S., Division of Obstetrics & Gynaecology, Clinical School, International Medical University, Seremban, Malaysia	[No abstract available]	trace element; anthropometry; Brunei Darussalam; Cambodia; diet therapy; dietary intake; female; gestational weight gain; health care planning; human; Indonesia; Laos; Malaysia; Myanmar; nutritional assessment; Philippines; physical activity; practice guideline; pregnancy diabetes mellitus; prevalence; Review; risk factor; risk reduction; Singapore; Southeast Asian; symposium; Thailand; Viet Nam; pregnancy; pregnancy diabetes mellitus; Southeast Asia; Asia, Southeastern; Diabetes, Gestational; Female; Humans; Pregnancy; Prevalence; Risk Factors	Springer Nature	09543007	33531635	Review	Q1	1024	4241	View
224	Putra M.A., Sukardi R., Grantomo J., Pratita J.	57215605850;56610228000;57211348862;57211348842;	Conventional Repair of an Intraoperatively Diagnosed Congenitally Corrected Transposition of the Great Arteries in an Adult	2021	The heart surgery forum	24	4		E769	E771		https://www.scopus.com/inward/record.uri?eid=2-s2.0-85117623116&doi=10.1532%2fhsf.3249&partnerID=40&md5=faae8b41db48824f15e78454a9e2e2b0	Thoracic and Cardiovascular Surgery Division, Department of Surgery, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo Hospital, Indonesia; Integrated Cardiovascular Service, Cipto Mangunkusumo Hospital, Indonesia	Putra, M.A., Thoracic and Cardiovascular Surgery Division, Department of Surgery, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo Hospital, Indonesia; Sukardi, R., Integrated Cardiovascular Service, Cipto Mangunkusumo Hospital, Indonesia; Grantomo, J., Thoracic and Cardiovascular Surgery Division, Department of Surgery, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo Hospital, Indonesia; Pratita, J., Thoracic and Cardiovascular Surgery Division, Department of Surgery, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo Hospital, Indonesia	BACKGROUND: Congenitally corrected transposition of the great arteries (ccTGA) is a rare condition that accounts for just 1% of all congenital heart disease. Diagnosis of ccTGA often is missed in adulthood, despite imaging and cardiology consultation. CASE REPORT: We present the case of an intraoperatively diagnosed ccTGA with severe tricuspid valve regurgitation and secundum atrial septal defect in a 54-year-old woman, who preoperatively was diagnosed with mitral valve regurgitation in atrioventricular and ventriculoarterial concordance heart. Intraoperatively, options considered were anatomical repair with atrial-arterial double switch operation after retraining the left ventricle or a conventional repair that focused on the associated defects without addressing the discordant connections. Considering our patient's age and condition, we decided to carry on with the conventional repair to prevent further systemic right ventricle dysfunction that may lead to poor outcome and decreased survival. She was discharged one week after surgery and resumed her normal activity at 3-month follow up. CONCLUSION: Although it rarely happens, CHD such as ccTGA in an adult must always be considered. Careful examination is essential. The treatment of ccTGA in an adult is challenging, with more limited options compared with pediatric patients. However, early management could still provide favorable outcomes.	case report; complication; female; heart septum defect; human; intraoperative period; middle aged; tricuspid valve regurgitation; Congenitally Corrected Transposition of the Great Arteries; Female; Heart Septal Defects, Atrial; Humans; Intraoperative Period; Middle Aged; Tricuspid Valve Insufficiency	NLM (Medline)	15226662	34473046	Article	Q3	255	16479	View
225	Tandaju J.R., Ii W., Barati-Boldaji R., Raeisi-Dehkordi H.	57222662533;57226738113;57204935735;57195065694;	Meta-analysis of statin and outcomes of coronavirus disease 2019 (COVID-19): Reconsideration is needed	2021	Nutrition, Metabolism and Cardiovascular Diseases	31	9		2737	2739	3	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85112531675&doi=10.1016%2fj.numecd.2021.06.009&partnerID=40&md5=51cf1abe5238935b3bcbca2d4b7a9969	Faculty of Medicine Universitas Indonesia Dr. Cipto Mangunkusumo National General Central Hospital, Jakarta, Indonesia; The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China; Nutrition Research Center, Shiraz University of Medical Sciences, Shiraz, Iran; Department of Nutrition, School of Public Health, Shahid Sadoughi University of Medical Sciences, Yazd, Iran	Tandaju, J.R., Faculty of Medicine Universitas Indonesia Dr. Cipto Mangunkusumo National General Central Hospital, Jakarta, Indonesia; Ii, W., The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China; Barati-Boldaji, R., Nutrition Research Center, Shiraz University of Medical Sciences, Shiraz, Iran; Raeisi-Dehkordi, H., Department of Nutrition, School of Public Health, Shahid Sadoughi University of Medical Sciences, Yazd, Iran	[No abstract available]	hydroxymethylglutaryl coenzyme A reductase inhibitor; human; COVID-19; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; SARS-CoV-2	Elsevier B.V.	09394753	34366177	Letter	Q1	1127	3665	View
241	Dharmawan Y., Fuady A., Korfage I., Richardus J.H.	57189353850;37085331400;6506984424;7003977198;	Individual and community factors determining delayed leprosy case detection: A systematic review	2021	PLoS Neglected Tropical Diseases	15	8	e0009651				https://www.scopus.com/inward/record.uri?eid=2-s2.0-85114085346&doi=10.1371%2fjournal.pntd.0009651&partnerID=40&md5=cd44ee5b8798b15d9e0def1be72603ab	Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands; Faculty of Public Health, Universitas Diponegoro, Semarang, Indonesia; Department of Community Medicine, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia	Dharmawan, Y., Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands, Faculty of Public Health, Universitas Diponegoro, Semarang, Indonesia; Fuady, A., Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands, Department of Community Medicine, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Korfage, I., Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands; Richardus, J.H., Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands	Background The number of new leprosy cases is declining globally, but the disability caused by leprosy remains an important disease burden. The chance of disability is increased by delayed case detection. This review focusses on the individual and community determinants of delayed leprosy case detection. Methods This study was conducted according to the PRISMA guidelines (Preferred Reporting Items for Systematic Reviews and Meta-Analysis). The study protocol is registered in PROS-PERO (code: CRD42020189274). To identify determinants of delayed detection, data was collected from five electronic databases: Embase.com, Medline All Ovid, Web of Science, Cochrane CENTRAL, and the WHO Global Health Library. Results We included 27 papers from 4315 records assessed. They originated in twelve countries, had been published between January 1, 2000, and January 31, 2021, and described the factors related to delayed leprosy case detection, the duration of the delayed case, and the percentage of Grade 2 Disability (G2D). The median delay in detection ranged from 12 to 36 months, the mean delay ranged from 11.5 to 64.1 months, and the percentage of G2D ranged from 5.6 to 43.2%. Health-service-seeking behavior was the most common factor associated with delayed detection. The most common individual factors were older age, being male, having a lower disease-symptom perception, having multibacillary leprosy, and lack of knowledge. The most common socioeconomic factors were living in a rural area, perform-ing agricultural labor, and being unemployed. Stigma was the most common social and community factor. Conclusions Delayed leprosy case detection is clearly correlated with increased disability and should therefore be a priority of leprosy programs. Interventions should focus on determinants of delayed case detection such as health-service-seeking behavior, and should consider rele-vant individual, socioeconomic, and community factors, including stigmatization. Further study is required of the health service-related factors contributing to delay. : © 2021 Dharmawan et al.	age distribution; attitude to health; awareness; delayed diagnosis; diagnosis time; disability; educational status; geographic distribution; help seeking behavior; human; leprosy; multibacillary leprosy; occupation; Review; risk perception; sex ratio; social belief; social determinants of health; social stigma; socioeconomics; systematic review; unemployment; complication; delayed diagnosis; disabled person; leprosy; patient attitude; psychology; risk factor; time to treatment; Delayed Diagnosis; Disabled Persons; Humans; Leprosy; Patient Acceptance of Health Care; Risk Factors; Social Stigma; Socioeconomic Factors; Time-to-Treatment	Public Library of Science	19352727	34383768	Review	Q1	1990	1322	View
244	Djaali W.	57212479564;	How Do You Treat Non-Insulin Dependent Diabetes in Your Practice?	2021	Medical Acupuncture	33	4		306	308		https://www.scopus.com/inward/record.uri?eid=2-s2.0-85113733355&doi=10.1089%2facu.2021.29182.cpl&partnerID=40&md5=d5215d516a5077a554bb640392817b63	Universitas Negeri Jakarta Jl. Rawamangun Muka East Jakarta, Jakarta, 13220, Indonesia; Department of Medical Acupuncture, Faculty of Medicine, Universitas Indonesia, RSUPN Dr. Cipto Mangunkusumo Central Jakarta, Jakarta, Indonesia	Djaali, W., Universitas Negeri Jakarta Jl. Rawamangun Muka East Jakarta, Jakarta, 13220, Indonesia, Department of Medical Acupuncture, Faculty of Medicine, Universitas Indonesia, RSUPN Dr. Cipto Mangunkusumo Central Jakarta, Jakarta, Indonesia	[No abstract available]	hemoglobin A1c; acupuncture; acupuncture point; adult; Article; case report; clinical article; evaluation study; evidence based practice; fatigue; glucose blood level; histology; human; male; middle aged; non insulin dependent diabetes mellitus; Research Diagnostic Criteria; signal transduction; somnolence; treatment planning	Mary Ann Liebert Inc.	19336586		Article	Q2	281	15498	View
245	Yunihastuti E., Hariyanto R., Sulaiman A.S., Harimurti K.	57221273925;57226819413;57216938482;23473513200;	Hepatitis C continuum of care: Experience of integrative hepatitis C treatment within a human immunodeficiency virus clinic in Indonesia	2021	PLoS ONE	16	8 August	e0256164				https://www.scopus.com/inward/record.uri?eid=2-s2.0-85112781600&doi=10.1371%2fjournal.pone.0256164&partnerID=40&md5=97994b56bdf101c196e7c76dcd7be446	Department Internal Medicine, Faculty of Medicine Universitas Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia; HIV Integrated Clinic, Cipto Mangunkusumo Hospital, Jakarta, Indonesia	Yunihastuti, E., Department Internal Medicine, Faculty of Medicine Universitas Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia, HIV Integrated Clinic, Cipto Mangunkusumo Hospital, Jakarta, Indonesia; Hariyanto, R., Department Internal Medicine, Faculty of Medicine Universitas Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia; Sulaiman, A.S., Department Internal Medicine, Faculty of Medicine Universitas Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia; Harimurti, K., Department Internal Medicine, Faculty of Medicine Universitas Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia	Introduction Direct-acting antiviral drugs (DAAs) have changed the paradigm of hepatitis C therapy for both HCV/HIV co-infected and HCV mono-infected patients. We aimed to describe the HCV continuum of care of HIV-infected patients treated in an HIV clinic after a free DAA program in Indonesia and identify factors correlated with sofosbuvir-daclatasvir (SOF-DCV) treatment failure. Methods We did a retrospective cohort study of adult HIV/HCV co-infected patients under routine HIV-care from November 2019 to April 2020 in the HIV integrated clinic of Cipto Mangunkusumo Hospital, Jakarta, Indonesia. We evaluated some factors correlated with sofosbuvir-daclatasvir treatment failure: gender, diabetes mellitus, previous IFN failure, cirrhosis, concomitant ribavirin use, high baseline HCV-RNA, and low CD4 cell count. Results and discussion Overall, 640 anti-HCV positive patients were included in the study. Most of them were male (88.3%) and former intravenous drug users (76.6%) with a mean age of 40.95 (SD 4.60) years old. Numbers and percentages for the stages of the HCV continuum of care were as follows: HCV-RNA tested (411; 64.2%), pre-therapeutic evaluation done (271; 42.3%), HCV treatment initiated (210; 32.8%), HCV treatment completed (207; 32.2%), but only 178 of these patients had follow-up HCV-RNA tests to allow SVR assessment; and finally SVR12 achieved (178; 27.8%). For the 184 who completed SOF-DCV treatment, SVR12 was achieved by 95.7%. In multivariate analysis, diabetes mellitus remained a significant factor correlated with SOF-DCV treatment failure (adjusted RR 17.0, 95%CI: 3.28–88.23, p = 0.001). Conclusions This study found that in the HCV continuum of care for HIV/HCV co-infected patients, gaps still exist at all stages. As the most commonly used DAA combination, sofosbuvir daclatasvir treatment proved to be effective and well-tolerated in HIV/HCV co-infected patients. Diabetes mellitus was significant factor correlated with not achieving SVR12 in this population. © 2021 Yunihastuti et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.	antiretrovirus agent; daclatasvir; efavirenz; elbasvir plus grazoprevir; interferon; lopinavir plus ritonavir; nevirapine; ribavirin; simeprevir; sofosbuvir; virus RNA; antivirus agent; adult; Article; CD4 lymphocyte count; cohort analysis; coinfection; controlled study; diabetes mellitus; drug withdrawal; fatigue; female; fever; follow up; gastrointestinal disease; gender; headache; hepatitis C; human; Human immunodeficiency virus infected patient; Human immunodeficiency virus infection; Indonesia; injection drug user; liver cirrhosis; major clinical study; male; multivariate analysis; myalgia; nausea; patient care; pruritus; retrospective study; RNA analysis; sleep disorder; sustained virologic response; university hospital; virus load; coinfection; drug effect; Hepacivirus; hepatitis C;	Public Library of Science	19326203	34383853	Article	Q1	990	4434	View
252	Reksodiputro M.H., Hutauruk S.M., Widodo D.W., Fardizza F., Mutia D.	35090488800;57205105620;56644646600;55091031700;57221630137;	Response to Letter by Spartalis et al: Platelet-Rich Fibrin in Total Laryngectomy: Further Study Concerns	2021	Facial Plastic Surgery	37	4		551	552		https://www.scopus.com/inward/record.uri?eid=2-s2.0-85111071840&doi=10.1055%2fs-0041-1729637&partnerID=40&md5=8aeb911188e8d4c1c7a3fd0986d70915	Department of Otorhinolaryngology-Head and Neck Surgery, Plastic Reconstructive Division, Faculty of Medicine, University of Indonesia, Jl Diponegoro No 71, DKI Jakarta, Jakarta, 10413, Indonesia; Division of Plastic Reconstructive, Department of Otorhinolaryngology-Head and Neck Surgery, Rumah Sakit Umum Pusat Nasional Dr Cipto Mangunkusumo, Central Jakarta, DKI Jakarta, Indonesia	Reksodiputro, M.H., Department of Otorhinolaryngology-Head and Neck Surgery, Plastic Reconstructive Division, Faculty of Medicine, University of Indonesia, Jl Diponegoro No 71, DKI Jakarta, Jakarta, 10413, Indonesia, Division of Plastic Reconstructive, Department of Otorhinolaryngology-Head and Neck Surgery, Rumah Sakit Umum Pusat Nasional Dr Cipto Mangunkusumo, Central Jakarta, DKI Jakarta, Indonesia; Hutauruk, S.M., Department of Otorhinolaryngology-Head and Neck Surgery, Plastic Reconstructive Division, Faculty of Medicine, University of Indonesia, Jl Diponegoro No 71, DKI Jakarta, Jakarta, 10413, Indonesia, Division of Plastic Reconstructive, Department of Otorhinolaryngology-Head and Neck Surgery, Rumah Sakit Umum Pusat Nasional Dr Cipto Mangunkusumo, Central Jakarta, DKI Jakarta, Indonesia; Widodo, D.W., Department of Otorhinolaryngology-Head and Neck Surgery, Plastic Reconstructive Division, Faculty of Medicine, University of Indonesia, Jl Diponegoro No 71, DKI Jakarta, Jakarta, 10413, Indonesia, Division of Plastic Reconstructive, Department of Otorhinolaryngology-Head and Neck Surgery, Rumah Sakit Umum Pusat Nasional Dr Cipto Mangunkusumo, Central Jakarta, DKI Jakarta, Indonesia; Fardizza, F., Department of Otorhinolaryngology-Head and Neck Surgery, Plastic Reconstructive Division, Faculty of Medicine, University of Indonesia, Jl Diponegoro No 71, DKI Jakarta, Jakarta, 10413, Indonesia, Division of Plastic Reconstructive, Department of Otorhinolaryngology-Head and Neck Surgery, Rumah Sakit Umum Pusat Nasional Dr Cipto Mangunkusumo, Central Jakarta, DKI Jakarta, Indonesia; Mutia, D., Department of Otorhinolaryngology-Head and Neck Surgery, Plastic Reconstructive Division, Faculty of Medicine, University of Indonesia, Jl Diponegoro No 71, DKI Jakarta, Jakarta, 10413, Indonesia	[No abstract available]	platelet-rich fibrin; human; laryngectomy; Humans; Laryngectomy; Platelet-Rich Fibrin	Thieme Medical Publishers, Inc.	07366825	34284502	Letter	Q3	435	11329	View
255	Surachman A.J.D., Yanuarso, Akbar D.L.	57222404106;57222408215;57219271823;	Corrigendum to “Emergency decompression and stabilization of 1st thoracic spinal cord injury and sacral fracture in a Covid-19 patient: A case report” [Int. J. Surg. 81 (2021) 105670] (International Journal of Surgery Case Reports (2021) 81, (S221026122100170X), (10.1016/j.ijscr.2021.105670))	2021	International Journal of Surgery Case Reports	85		106162				https://www.scopus.com/inward/record.uri?eid=2-s2.0-85110716581&doi=10.1016%2fj.ijscr.2021.106162&partnerID=40&md5=d755a2c74f6f517c9ab61ce17d1d60b7	Orthopaedics and Traumatology Department, Indonesia Army Central Hospital, Jakarta, Indonesia; Resident of Orthopaedics and Traumatology Department, Dr. Cipto Mangunkusumo National Central General Hospital, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia	Surachman, A.J.D., Orthopaedics and Traumatology Department, Indonesia Army Central Hospital, Jakarta, Indonesia; Yanuarso, Orthopaedics and Traumatology Department, Indonesia Army Central Hospital, Jakarta, Indonesia; Akbar, D.L., Resident of Orthopaedics and Traumatology Department, Dr. Cipto Mangunkusumo National Central General Hospital, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia	The authors regret: [1] The published sentence should have read: “For the pubic diastasis, we did not put any fixation since the diastasis was 1 cm (Fig. 4). When we did the follow up, there was unstable on the diastasis, then we did internal fixation on it and the result of the post surgery was evaluated by pelvic radiograph (Fig. 5) [9].” [2] Fig. 5 should have been published as follows: [3] The authors wish to add the following acknowledgement: “Nadya Zaragita, resident of neurosurgery department of Faculty of Medicine, Universitas Indonesia for making illustration of sacral fracture fixation method.” The authors would like to apologise for any inconvenience caused. © 2021	erratum	Elsevier Ltd	22102612		Erratum	Q3	232	17549	View
265	Yuliwulandari R., Shin J.G., Kristin E., Suyatna F.D., Prahasto I.D., Prayuni K., Mahasirimongkol S., Cavallari L.H., Mitropoulou C., Patrinos G.P., Hao J., Williams M.S., Snyder S.R.	23098874600;56031235700;6504458442;56039633100;57222660319;57190022456;14632559000;8396168500;37001846100;6603726539;57194283820;57203332674;7401687524;	Cost-effectiveness analysis of genotyping for HLA-B*15:02 in Indonesian patients with epilepsy using a generic model	2021	Pharmacogenomics Journal	21	4		476	483	1	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85103643380&doi=10.1038%2fs41397-021-00225-9&partnerID=40&md5=927cb9a5fa739ff5a932d25eb4459bd0	Department of Pharmacology, Faculty of Medicine, YARSI University, Jakarta Pusat, Indonesia; Genetic Research Center, YARSI Research Institute, YARSI University, Jakarta Pusat, Indonesia; Department of Pharmacology and Pharmacogenomics Research Center, Inje University College of Medicine, Busan, South Korea; Department of Clinical Pharmacology, Inje University Busan Paik Hospital, Busan, South Korea; Department of Pharmacology and Therapy, Faculty of Medicine, Gadjah Mada University, Yogyakarta, Indonesia; Department of Pharmacology & Therapeutic, Faculty of Medicine, Universitas Indonesia, Jakarta Pusat, Indonesia; Medical Genetics Section, Department of Medical Sciences, Ministry of Public Health, Nonthaburi, Thailand; Department of Pharmacotherapy and Translational Research, University of Florida, Gainesville, FL, United States; The Golden Helix Foundation, London, United Kingdom; Department of Pharmacy, University of Patras, Patras, Greece; Department of Pathology, United Arab Emirates University College of Medicine and Health Sciences, Al-Ain, United Arab Emirates; Department of Population Health Sciences, Geisinger, Danville, PA, United States; Genomic Medicine Institute, Geisinger, Danville, PA, United States; Health Policy & Behavioral Sciences, Georgia State University, Atlanta, GA, United States	Yuliwulandari, R., Department of Pharmacology, Faculty of Medicine, YARSI University, Jakarta Pusat, Indonesia, Genetic Research Center, YARSI Research Institute, YARSI University, Jakarta Pusat, Indonesia; Shin, J.G., Department of Pharmacology and Pharmacogenomics Research Center, Inje University College of Medicine, Busan, South Korea, Department of Clinical Pharmacology, Inje University Busan Paik Hospital, Busan, South Korea; Kristin, E., Department of Pharmacology and Therapy, Faculty of Medicine, Gadjah Mada University, Yogyakarta, Indonesia; Suyatna, F.D., Department of Pharmacology & Therapeutic, Faculty of Medicine, Universitas Indonesia, Jakarta Pusat, Indonesia; Prahasto, I.D., Department of Pharmacology and Therapy, Faculty of Medicine, Gadjah Mada University, Yogyakarta, Indonesia; Prayuni, K., Genetic Research Center, YARSI Research Institute, YARSI University, Jakarta Pusat, Indonesia; Mahasirimongkol, S., Medical Genetics Section, Department of Medical Sciences, Ministry of Public Health, Nonthaburi, Thailand; Cavallari, L.H., Department of Pharmacotherapy and Translational Research, University of Florida, Gainesville, FL, United States; Mitropoulou, C., The Golden Helix Foundation, London, United Kingdom; Patrinos, G.P., Department of Pharmacy, University of Patras, Patras, Greece, Department of Pathology, United Arab Emirates University College of Medicine and Health Sciences, Al-Ain, United Arab Emirates; Hao, J., Department of Population Health Sciences, Geisinger, Danville, PA, United States; Williams, M.S., Genomic Medicine Institute, Geisinger, Danville, PA, United States; Snyder, S.R., Health Policy & Behavioral Sciences, Georgia State University, Atlanta, GA, United States	Carbamazepine (CBZ)-induced Stevens–Johnson syndrome and toxic epidermal necrolysis (SJS/TEN) are strongly associated with the HLA-B15:02 allele. Screening HLA-B15:02 before CBZ administration might prevent CBZ-induced SJS/TEN by enabling clinicians to prescribe alternative therapy for positive patients. Similar to other Southeastern Asian countries, HLA-B15:02 is highly prevalent in Indonesia. Therefore, we assessed the economic value of HLA-B15:02 screening before CBZ prescription to patients with epilepsy in Indonesia. A generic cost-effectiveness model and decision support tool, developed to enable users to perform an initial cost-effectiveness analysis from a healthcare provider/payer perspective, were used to assess the value of HLA-B15:02 genotyping. The incremental cost-effectiveness ratio of adopting universal HLA-B15:02 screening was 656,444,671 Indonesian Rupiah (IDR)/quality-adjusted life year (QALY) gained for patients compared with 2,634,975,574 IDR/QALY gained for providing valproic acid (alternative drug) without screening. Thus, neither HLA-B*15:02 screening nor substitution with VPA meets the Indonesian threshold for cost effectiveness. However, the improved outcomes with this test in other Asian countries may inform the desirability of implementation in Indonesia even with suboptimal cost-effectiveness. © 2021, The Author(s), under exclusive licence to Springer Nature Limited.	anticonvulsive agent; carbamazepine; HLA B antigen; valproic acid; anticonvulsive agent; carbamazepine; HLA B15 antigen; aged; Article; cost effectiveness analysis; epilepsy; epileptic patient; female; genotyping; human; Indonesian; Javanese (people); major clinical study; male; predictive value; prevalence; quality adjusted life year; sensitivity analysis; sensitivity and specificity; Stevens Johnson syndrome; Sundanese (people); toxic epidermal necrolysis; adult; allele; Asian; cost benefit analysis; epilepsy; genetic predisposition; genetic screening; genetics; genotype; Indonesia; procedures; risk factor; Adult; Alleles; Anticonvulsants; Asians; Carbamazepine; Cost-Benefit Analysis; Epilepsy; Female; Genetic Predisposition to Disease; Genetic Testing; Genotype; HLA-B15 Antigen; Humans;	Springer Nature	1470269X	33824430	Article	Q2	804	6015	View

Publikasi Scopus 926 artikel (Per 14 Maret 2022)